Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0028738 (
nystagmus
)
7,431
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Wernicke's encephalopathy (WE) is a severe
brain disorder
, first described in 1881, and is caused by a nutritional deficiency of thiamine (vitamin B1) found mostly in patients suffering from chronic alcoholism. In addition, WE can also complicate bariatric surgery if adequate vitamin supplementation is not insured. Without immediate treatment, the prognosis is poor and the mortality rate is high. Most patients present with atypical neurological symptoms, which hampers rapid diagnosis. We present a 40-year-old woman who underwent gastroplasty combined with gastric banding for severe obesity. She experienced repetitive vomiting and her diet was without vitamin supplementation. After three months she developed convergent strabismus, apathy and urinary incontinence, which was diagnosed as WE and treated as such. Six months later her recovery was incomplete, still showing gait difficulties and
nystagmus
. We aim to show that adequate vitamin supplementation in patients undergoing gastroplasty is necessary, especially considering the risk of permanent neurological deficits.
...
PMID:Vitamin B1 in the treatment of Wernicke's encephalopathy due to hyperemesis after gastroplasty. 2272 4
Intellectual disability (ID) is a clinically and genetically heterogeneous developmental
brain disorder
. The present study describes two male siblings, aged 7 and 1 yr old, with severe ID, spastic quadriplegia,
nystagmus
, and brain atrophy with acquired microcephaly. We used the exome sequencing to identify the causative gene in the patients and identified a hemizygous missense variant, c.1282T>A (p.W428R), in the p21-activated serine/threonine kinase 3 gene (
PAK3
), which is associated with X-linked ID. p.W428R is located within the highly conserved kinase domain and was predicted to induce loss of enzymatic function by three mutation prediction tools (SIFT, PolyPhen-2, and MutationTaster). In addition, this variant has not been reported in public databases (as of the middle of December 2018) or in the data from 3275 individuals of the Japanese general population analyzed using high-depth whole-genome sequencing. To date, only 13 point mutations and deletions in
PAK3
in ID have been reported. The literature review illustrated a phenotypic spectrum of
PAK3
pathogenic variant, and our cases represented the most severe form of the
PAK3
-associated phenotypes. This is the first report of a
PAK3
pathogenic variant in Japanese patients with X-linked ID.
...
PMID:A novel
PAK3
pathogenic variant identified in two siblings from a Japanese family with X-linked intellectual disability: case report and review of the literature. 3144 67